Radcliffe Capital Management, L.P. - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 41 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$4,223,984
+2.0%
412,0960.0%0.26%
+101.5%
Q4 2022$4,141,565
+2.1%
412,096
+0.1%
0.13%
+33.7%
Q3 2022$4,055,000
+1.2%
411,505
+0.0%
0.10%
+6.5%
Q2 2022$4,006,000
+3.0%
411,475
+3.0%
0.09%
+4.5%
Q1 2022$3,890,000
-0.2%
399,3720.0%0.09%
-13.7%
Q4 2021$3,896,000
-0.4%
399,372
-0.2%
0.10%
-10.5%
Q3 2021$3,912,000400,0000.11%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,199,000$11,672,0000.82%
MMCAP International Inc. SPC 800,000$7,788,0000.62%
Arena Capital Advisors, LLC- CA 250,917$2,443,0000.62%
Atalaya Capital Management LP 500,000$4,870,0000.58%
DG Capital Management, LLC 127,665$1,243,0000.45%
Kepos Capital LP 500,000$4,868,0000.44%
KIM, LLC 800,000$7,792,0000.37%
ANGELO GORDON & CO., L.P. 300,000$2,921,0000.32%
FIR TREE CAPITAL MANAGEMENT LP 950,803$9,261,0000.29%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,868,0000.28%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders